Edwards Lifesciences Corporation Litigation Settlement, Expense
Edwards Lifesciences Corporation (EW) reported Litigation Settlement, Expense of $6.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LitigationSettlementExpense · last filed 2026-08-04
- Edwards Lifesciences Corporation litigation settlement, expense for the quarter ending 2026-06-30 was $6.30M, a 59.35% decline year-over-year.
- Edwards Lifesciences Corporation litigation settlement, expense for the quarter ending 2026-03-31 was $37.10M, a 240.37% increase year-over-year.
- Edwards Lifesciences Corporation litigation settlement, expense for the quarter ending 2025-12-31 was $208.60M, a 1555.56% increase year-over-year.
- Edwards Lifesciences Corporation litigation settlement, expense for the quarter ending 2025-09-30 was $90.40M, a 737.04% increase year-over-year.
- Edwards Lifesciences Corporation litigation settlement, expense for fiscal 2025 was $325.40M, a 705.45% increase from fiscal 2024.
- Edwards Lifesciences Corporation litigation settlement, expense for fiscal 2024 was $40.40M, a 80.15% decline from fiscal 2023.
- Edwards Lifesciences Corporation litigation settlement, expense for fiscal 2023 was $203.50M, a 1187.97% increase from fiscal 2022.
- Edwards Lifesciences Corporation litigation settlement, expense for fiscal 2022 was $15.80M, a 23.30% decline from fiscal 2021.
| Period end | Litigation Settlement, Expense 3 month | Litigation Settlement, Expense 6 month | Litigation Settlement, Expense 9 month | Litigation Settlement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.30M 10-Q · filed 2026-08-04 | $43.40M 10-Q · filed 2026-08-04 | $252.00M derived: sum of 3 quarters · filed 2026-08-04 | $342.40M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $37.10M 10-Q · filed 2026-05-06 | $245.70M derived: sum of 2 quarters · filed 2026-05-06 | $336.10M derived: sum of 3 quarters · filed 2026-05-06 | $351.60M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $208.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $299.00M derived: sum of 2 quarters · filed 2026-02-25 | $314.50M derived: sum of 3 quarters · filed 2026-08-04 | $325.40M 10-K · filed 2026-02-25 |
| 2025-09-30 | $90.40M 10-Q · filed 2025-11-05 | $105.90M derived: sum of 2 quarters · filed 2026-08-04 | $116.80M 10-Q · filed 2025-11-05 | $129.40M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $15.50M 10-Q · filed 2026-08-04 | $26.40M 10-Q · filed 2026-08-04 | $39.00M derived: sum of 3 quarters · filed 2026-08-04 | $49.80M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $10.90M 10-Q · filed 2026-05-06 | $23.50M derived: sum of 2 quarters · filed 2026-05-06 | $34.30M derived: sum of 3 quarters · filed 2026-05-06 | $42.40M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $12.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $23.40M derived: sum of 2 quarters · filed 2026-02-25 | $31.50M derived: sum of 3 quarters · filed 2026-02-25 | $40.40M 10-K · filed 2026-02-25 |
| 2024-09-30 | $10.80M 10-Q · filed 2025-11-05 | $18.90M derived: sum of 2 quarters · filed 2025-11-05 | $27.80M 10-Q · filed 2025-11-05 | $37.70M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $8.10M 10-Q · filed 2025-08-06 | $17.00M 10-Q · filed 2025-08-06 | $26.90M derived: sum of 3 quarters · filed 2026-02-25 | $29.10M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $8.90M 10-Q · filed 2025-05-06 | $18.80M derived: sum of 2 quarters · filed 2026-02-25 | $21.00M derived: sum of 3 quarters · filed 2026-02-25 | $168.90M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $9.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $12.10M derived: sum of 2 quarters · filed 2026-02-25 | $160.00M derived: sum of 3 quarters · filed 2026-02-25 | $203.50M 10-K · filed 2026-02-25 |
| 2023-09-30 | $2.20M 10-Q · filed 2024-11-06 | $150.10M derived: sum of 2 quarters · filed 2024-11-06 | $193.60M 10-Q · filed 2024-11-06 | $198.60M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $147.90M 10-Q · filed 2024-07-31 | $191.40M 10-Q · filed 2024-07-31 | $196.40M derived: sum of 3 quarters · filed 2025-02-28 | $194.00M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $43.50M 10-Q · filed 2024-04-29 | $48.50M derived: sum of 2 quarters · filed 2025-02-28 | $46.10M derived: sum of 3 quarters · filed 2025-02-28 | $52.20M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $2.60M derived: sum of 2 quarters · filed 2025-02-28 | $8.70M derived: sum of 3 quarters · filed 2025-02-28 | $15.80M 10-K · filed 2025-02-28 |
| 2022-09-30 | -$2.40M 10-Q · filed 2023-10-27 | $3.70M derived: sum of 2 quarters · filed 2023-10-27 | $10.80M 10-Q · filed 2023-10-27 | $17.90M derived: sum of 4 quarters · filed 2023-10-27 |
| 2022-06-30 | $6.10M 10-Q · filed 2023-07-28 | $13.20M 10-Q · filed 2023-07-28 | $20.30M derived: sum of 3 quarters · filed 2023-07-28 | $25.00M derived: sum of 4 quarters · filed 2023-07-28 |
| 2022-03-31 | $7.10M 10-Q · filed 2023-04-28 | $14.20M derived: sum of 2 quarters · filed 2023-04-28 | $18.90M derived: sum of 3 quarters · filed 2023-04-28 | $21.30M derived: sum of 4 quarters · filed 2023-04-28 |
| 2021-12-31 | $7.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $11.80M derived: sum of 2 quarters · filed 2023-02-13 | $14.20M derived: sum of 3 quarters · filed 2023-02-13 | $20.60M 10-K · filed 2023-02-13 |
| 2021-09-30 | $4.70M 10-Q · filed 2022-10-28 | $7.10M derived: sum of 2 quarters · filed 2022-10-28 | $13.50M 10-Q · filed 2022-10-28 | $18.10M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-06-30 | $2.40M 10-Q · filed 2022-07-29 | $8.80M 10-Q · filed 2022-07-29 | $13.40M derived: sum of 3 quarters · filed 2023-02-13 | $21.80M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-03-31 | $6.40M 10-Q · filed 2022-04-28 | $11.00M derived: sum of 2 quarters · filed 2023-02-13 | $19.40M derived: sum of 3 quarters · filed 2023-02-13 | $399.30M derived: sum of 4 quarters · filed 2023-02-13 |
| 2020-12-31 | $4.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $13.00M derived: sum of 2 quarters · filed 2023-02-13 | $392.90M derived: sum of 3 quarters · filed 2023-02-13 | $405.40M 10-K · filed 2023-02-13 |
| 2020-09-30 | $8.40M 10-Q · filed 2021-10-29 | $388.30M derived: sum of 2 quarters · filed 2021-10-29 | $400.80M 10-Q · filed 2021-10-29 | $414.70M derived: sum of 4 quarters · filed 2022-02-14 |
| 2020-06-30 | $379.90M 10-Q · filed 2021-07-30 | $392.40M 10-Q · filed 2021-07-30 | $406.30M derived: sum of 3 quarters · filed 2022-02-14 | $414.20M derived: sum of 4 quarters · filed 2022-02-14 |
| 2020-03-31 | $12.50M 10-Q · filed 2021-04-28 | $26.40M derived: sum of 2 quarters · filed 2022-02-14 | $34.30M derived: sum of 3 quarters · filed 2022-02-14 | $41.30M derived: sum of 4 quarters · filed 2022-02-14 |
| 2019-12-31 | $13.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $21.80M derived: sum of 2 quarters · filed 2022-02-14 | $28.80M derived: sum of 3 quarters · filed 2022-02-14 | $33.40M 10-K · filed 2022-02-14 |
| 2019-09-30 | $7.90M 10-Q · filed 2020-10-26 | $14.90M derived: sum of 2 quarters · filed 2020-10-26 | $19.50M 10-Q · filed 2020-10-26 | $214.40M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | $7.00M 10-Q · filed 2020-07-27 | $11.60M 10-Q · filed 2020-07-27 | $206.50M derived: sum of 3 quarters · filed 2021-02-12 | $214.40M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | $4.60M 10-Q · filed 2020-04-28 | $199.50M derived: sum of 2 quarters · filed 2021-02-12 | $207.40M derived: sum of 3 quarters · filed 2021-02-12 | $212.90M derived: sum of 4 quarters · filed 2021-02-12 |
| 2018-12-31 | $194.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $202.80M derived: sum of 2 quarters · filed 2021-02-12 | $208.30M derived: sum of 3 quarters · filed 2021-02-12 | $214.00M 10-K · filed 2021-02-12 |
| 2018-09-30 | $7.90M 10-Q · filed 2019-10-25 | $13.40M derived: sum of 2 quarters · filed 2019-10-25 | $19.10M 10-Q · filed 2019-10-25 | -$85.80M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-06-30 | $5.50M 10-Q · filed 2019-07-26 | $11.20M 10-Q · filed 2019-07-26 | -$93.70M derived: sum of 3 quarters · filed 2020-02-14 | -$80.00M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-03-31 | $5.70M 10-Q · filed 2019-04-26 | -$99.20M derived: sum of 2 quarters · filed 2020-02-14 | -$85.50M derived: sum of 3 quarters · filed 2020-02-14 | -$77.80M derived: sum of 4 quarters · filed 2020-02-14 |
| 2017-12-31 | -$104.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | -$91.20M derived: sum of 2 quarters · filed 2020-02-14 | -$83.50M derived: sum of 3 quarters · filed 2020-02-14 | -$73.30M 10-K · filed 2020-02-14 |
| 2017-09-30 | $13.70M 10-Q · filed 2018-10-26 | $21.40M derived: sum of 2 quarters · filed 2018-10-26 | $31.60M 10-Q · filed 2018-10-26 | $36.40M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | $7.70M 10-Q · filed 2018-07-27 | $17.90M 10-Q · filed 2018-07-27 | $22.70M derived: sum of 3 quarters · filed 2019-02-15 | $29.20M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-03-31 | $10.20M 10-Q · filed 2018-04-27 | $15.00M derived: sum of 2 quarters · filed 2019-02-15 | $21.50M derived: sum of 3 quarters · filed 2019-02-15 | $30.60M derived: sum of 4 quarters · filed 2019-02-15 |
| 2016-12-31 | $4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $11.30M derived: sum of 2 quarters · filed 2019-02-15 | $20.40M derived: sum of 3 quarters · filed 2019-02-15 | $32.60M 10-K · filed 2019-02-15 |
| 2016-09-30 | $6.50M 10-Q · filed 2017-10-27 | $15.60M derived: sum of 2 quarters · filed 2017-10-27 | $27.80M 10-Q · filed 2017-10-27 | |
| 2016-06-30 | $9.10M 10-Q · filed 2017-07-28 | $21.30M 10-Q · filed 2017-07-28 | ||
| 2016-03-31 | $12.20M 10-Q · filed 2017-04-28 | |||
| 2015-12-31 | $7.00M 10-K · filed 2018-02-16 | |||
| 2014-12-31 | -$740.40M 10-K · filed 2017-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |